Evidence map›Paper›PMID 41078453›Full record

ArticleFood science & nutrition2025

Comparison of Antioxidant and Anti-Melanogenic Activity of γ-Oryzanol and Gallic Acid by Inhibiting Tyrosinase Activity in B16F10 Mouse Melanoma Cells.

Seyed Ahmad Emami, Elham Hadipour, Motahareh Boozari, Mahdieh Andalib, Maryam Asnaashari, Zahra Tayarani-Najaran

Abstract read
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seyed Ahmad EmamiDepartment of Traditional Pharmacy School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran.
Elham HadipourDepartment of Biology, Faculty of Sciences University of Guilan Rasht Iran.ORCID https://orcid.org/0000-0002-3764-4606
Motahareh BoozariDepartment of Pharmacognosy, School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran.
Mahdieh AndalibMedical Toxicology Research Center Mashhad University of Medical Sciences Mashhad Iran.
Maryam AsnaashariDepartment of Animal Processing, Animal Science Research Institute of Iran (ASRI) Agricultural Research, Education and Extension Organization (AREEO) Karaj Iran.ORCID https://orcid.org/0000-0003-3188-0680
Zahra Tayarani-NajaranTargeted Drug Delivery Research Center, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran.ORCID https://orcid.org/0000-0001-8899-0886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rice bran is abundant in gallic acid, and γ-oryzanol comprises a mixture of ferulic acid esters and phytosterols. We compared the antioxidant and anti-melanogenic activities of gallic acid and γ-oryzanol to treat disorders caused by hyperpigmentation. The antioxidant activity was measured by 2,2'-diphenyl-1-picrylhydrazyl radical (DPPH) and ferric-reducing antioxidant power (FRAP) methods. Then, its effects on viability, reactive oxygen species (ROS) production, mushroom tyrosinase, and melanin content were investigated on B16F10 murine melanoma cell line. The antioxidant effects of γ-oryzanol were higher than those of gallic acid in DPPH and FRAP tests. γ-oryzanol and gallic acid did not show a significant cytotoxic effect and also reduced the amount of ROS. In addition, the reduction of mushroom tyrosinase activity in γ-oryzanol was more than that in gallic acid. A decrease in melanin content was observed in γ-oryzanol and gallic acid. So, it can be concluded that γ-oryzanol has more antioxidant and higher inhibitory effects in the expression pathway of proteins involved in melanin synthesis in B16F10 cells than gallic acid.

Indexed as

gallic acidMITFrice brantyrosinaseγ‐oryzanol

Identifiers

PMID41078453
PMCPMC12514338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.